Industrial Applicability of Bioscience Inventions in the Supreme Court

Research output: Contribution to journalArticle

Abstract

When researchers discover new genes and proteins, what threshold of “industrial applicability” must be met in patent law? This note addresses this question from the perspective of the leading UK Supreme Court decision, HGS v Eli Lilly (2011).
Original languageEnglish
Pages (from-to)50-52
JournalCambridge Law Journal
Volume71
Issue number1
DOIs
Publication statusPublished - 1 Jan 2012
Externally publishedYes

Fingerprint

patent law
court decision
invention
Supreme Court

Cite this

@article{1a59ea26bf0143aa8de128333ffbe425,
title = "Industrial Applicability of Bioscience Inventions in the Supreme Court",
abstract = "When researchers discover new genes and proteins, what threshold of “industrial applicability” must be met in patent law? This note addresses this question from the perspective of the leading UK Supreme Court decision, HGS v Eli Lilly (2011).",
keywords = "patent law, invention, bioscience, European Patent Convention",
author = "Julia Powles",
year = "2012",
month = "1",
day = "1",
doi = "10.1017/S0008197312000165",
language = "English",
volume = "71",
pages = "50--52",
journal = "Cambridge Law Journal",
issn = "0008-1973",
publisher = "Stevens & Sons",
number = "1",

}

Industrial Applicability of Bioscience Inventions in the Supreme Court. / Powles, Julia.

In: Cambridge Law Journal, Vol. 71, No. 1, 01.01.2012, p. 50-52.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Industrial Applicability of Bioscience Inventions in the Supreme Court

AU - Powles, Julia

PY - 2012/1/1

Y1 - 2012/1/1

N2 - When researchers discover new genes and proteins, what threshold of “industrial applicability” must be met in patent law? This note addresses this question from the perspective of the leading UK Supreme Court decision, HGS v Eli Lilly (2011).

AB - When researchers discover new genes and proteins, what threshold of “industrial applicability” must be met in patent law? This note addresses this question from the perspective of the leading UK Supreme Court decision, HGS v Eli Lilly (2011).

KW - patent law

KW - invention

KW - bioscience

KW - European Patent Convention

UR - http://www.scopus.com/inward/record.url?scp=85022872975&partnerID=8YFLogxK

U2 - 10.1017/S0008197312000165

DO - 10.1017/S0008197312000165

M3 - Article

VL - 71

SP - 50

EP - 52

JO - Cambridge Law Journal

JF - Cambridge Law Journal

SN - 0008-1973

IS - 1

ER -